{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:41:53Z","timestamp":1789659713233,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.bcp.2011.01.017","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T04:33:40Z","timestamp":1296621220000},"page":"881-890","source":"Crossref","is-referenced-by-count":74,"title":["Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma"],"prefix":"10.1016","volume":"81","author":[{"given":"Wenqing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence S.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rimsza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise J.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Manziolli. Daniel O.","family":"Persky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daruka","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.01.017_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc1526","article-title":"Aurora-A\u2014a guardian of poles","volume":"5","author":"Marumoto","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.01.017_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35048096","article-title":"Mitotic kinases as regulators of cell division and its checkpoints","volume":"2","author":"Nigg","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"Pt 21","key":"10.1016\/j.bcp.2011.01.017_bib0020","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1242\/jcs.112.21.3591","article-title":"Aurora\/Ipl1p-related kinases, a new oncogenic family of mitotic serine\u2013threonine kinases","volume":"112","author":"Giet","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2011.01.017_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00412-003-0265-1","article-title":"Regulation of Aurora-A kinase on the mitotic spindle","volume":"112","author":"Kufer","year":"2003","journal-title":"Chromosoma"},{"key":"10.1016\/j.bcp.2011.01.017_bib0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1083\/jcb.200305048","article-title":"Interaction of Aurora-A and centrosomin at the microtubule-nucleating site in Drosophila and mammalian cells","volume":"162","author":"Terada","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-8674(95)90374-7","article-title":"Mutations in Aurora prevent centrosome separation leading to the formation of monopolar spindles","volume":"81","author":"Glover","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200108135","article-title":"Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules","volume":"156","author":"Giet","year":"2002","journal-title":"J Cell Biol"},{"issue":"Pt 5","key":"10.1016\/j.bcp.2011.01.017_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1242\/jcs.111.5.557","article-title":"The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly","volume":"111","author":"Roghi","year":"1998","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2011.01.017_bib0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.200108051","article-title":"Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans","volume":"155","author":"Hannak","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0055","doi-asserted-by":"crossref","first-page":"51786","DOI":"10.1074\/jbc.M306275200","article-title":"Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells","volume":"278","author":"Marumoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.01.017_bib0060","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/0008-5472.CAN-04-3981","article-title":"RNA interference targeting Aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells","volume":"65","author":"Hata","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.01.017_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0092-8674(03)00642-1","article-title":"Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells","volume":"114","author":"Hirota","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0070","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1365-2443.2002.00592.x","article-title":"Roles of Aurora-a kinase in mitotic entry and G2 checkpoint in mammalian cells","volume":"7","author":"Marumoto","year":"2002","journal-title":"Genes Cells"},{"key":"10.1016\/j.bcp.2011.01.017_bib0075","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1073\/pnas.0601425103","article-title":"Aurora a, mitotic entry, and spindle bipolarity","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.01.017_bib0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of Aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200208092","article-title":"The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore\u2013microtubule attachment and in maintaining the spindle assembly checkpoint","volume":"161","author":"Hauf","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0090","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1091\/mbc.E02-11-0769","article-title":"Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis","volume":"14","author":"Honda","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0960-9822(02)00848-5","article-title":"The kinase activity of Aurora B is required for kinetochore\u2013microtubule interactions during mitosis","volume":"12","author":"Murata-Hori","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200208091","article-title":"Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores","volume":"161","author":"Ditchfield","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cm.20039","article-title":"Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells","volume":"59","author":"Sasai","year":"2004","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.bcp.2011.01.017_bib0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tcb.2005.03.004","article-title":"Aurora kinases, aneuploidy and cancer, a coincidence or a real link?","volume":"15","author":"Giet","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/2496","article-title":"Tumour amplified kinase STK15\/BTAK induces centrosome amplification, aneuploidy and transformation","volume":"20","author":"Zhou","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2011.01.017_bib0120","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/emboj\/17.11.3052","article-title":"A homologue of Drosophila Aurora kinase is oncogenic and amplified in human colorectal cancers","volume":"17","author":"Bischoff","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2011.01.017_bib0125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1568026054637719","article-title":"Progress in the development of selective inhibitors of Aurora kinases","volume":"5","author":"Mortlock","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2011.01.017_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2141.2003.04311.x","article-title":"Aurora2\/BTAK\/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma","volume":"121","author":"Hamada","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.21370","article-title":"Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma","volume":"118","author":"Camacho","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.01.017_bib0140","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-05-0146","article-title":"Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures","volume":"4","author":"Mahadevan","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.01.017_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharma.2008.12.005","article-title":"[Inhibitors of Aurora kinases]","volume":"67","author":"Pinel","year":"2009","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.bcp.2011.01.017_bib0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd2907","article-title":"Cell cycle kinases as therapeutic targets for cancer","volume":"8","author":"Lapenna","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2011.01.017_bib0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1097-2765(03)00392-7","article-title":"Structural basis of Aurora-A activation by TPX2 at the mitotic spindle","volume":"12","author":"Bayliss","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0165","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","article-title":"Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells","volume":"7","author":"D\u2019Alise","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.01.017_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568011033353524","article-title":"Structure-based design of novel anti-cancer agents targeting Aurora kinases","volume":"3","author":"Mahadevan","year":"2003","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.bcp.2011.01.017_bib0175","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1073\/pnas.0608798104","article-title":"Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase","volume":"104","author":"Manfredi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.01.017_bib0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2011.01.017_bib0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1535-6108(02)00235-0","article-title":"Aurora-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol","volume":"3","author":"Anand","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2011.01.017_bib0190","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4161\/cc.8.6.7897","article-title":"The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents","volume":"8","author":"Wysong","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2011.01.017_bib0195","doi-asserted-by":"crossref","unstructured":"Shimomura T, Hasako S, Nakatsuru Y, Mita T, Ichikawa K, Kodera T, et al. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther 2010;9:157\u201366.","DOI":"10.1158\/1535-7163.MCT-09-0609"},{"key":"10.1016\/j.bcp.2011.01.017_bib0200","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","article-title":"Murine models to evaluate novel and conventional therapeutic strategies for cancer","volume":"170","author":"Talmadge","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gde.2003.11.006","article-title":"Aurora kinases link chromosome segregation and cell division to cancer susceptibility","volume":"14","author":"Meraldi","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.bcp.2011.01.017_bib0210","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1535-7163.MCT-08-0754","article-title":"The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model","volume":"8","author":"VanderPorten","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.01.017_bib0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2400555","article-title":"Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)","volume":"11","author":"Jadayel","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2011.01.017_bib0220","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1200\/JCO.1995.13.3.583","article-title":"Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma","volume":"13","author":"Younes","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.1998.16.2.574","article-title":"Phase II trial of paclitaxel by 24-h continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246","volume":"16","author":"Press","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/JCO.1995.13.2.381","article-title":"Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas","volume":"13","author":"Wilson","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.01.017_bib0235","first-page":"502","article-title":"Phase II study of 3-h infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"85","author":"Casasnovas","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2011.01.017_bib0240","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6600914","article-title":"Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma","volume":"88","author":"Zekri","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2011.01.017_bib0245","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/cncr.20245","article-title":"Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma","volume":"100","author":"Rizzieri","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2011.01.017_bib0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CNV-46484","article-title":"Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study","volume":"23","author":"Kahl","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bcp.2011.01.017_bib0255","first-page":"123","article-title":"Paclitaxel-based treatment of lymphoma","volume":"26","author":"Younes","year":"1999","journal-title":"Semin Oncol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T06:12:03Z","timestamp":1637215923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0006295211000748"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.01.017","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}